Cargando…
HER2 Expression in Peritoneal Dissemination of High-Grade Serous Ovarian Carcinoma: A Comparative Study of Immunohistochemical Reactivity Using Four HER2 Antibodies
Most high-grade serous ovarian carcinomas (HGSOCs) involving the peritoneum are aggressive. Epidermal growth factor receptor 2 (HER2) is aberrantly activated in a variety of solid cancers. The HER2 status of a tumor is based on cytoplasmic membrane staining of an intracellular domain (ICD)-specific...
Autores principales: | Yeo, Min-Kyung, Kim, Sup, Yoo, Heon Jong, Suh, Kwang-Sun, Kim, Kyung-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741327/ https://www.ncbi.nlm.nih.gov/pubmed/36498537 http://dx.doi.org/10.3390/jcm11236963 |
Ejemplares similares
-
The frequency and clinical impact of HER2 alterations in lung adenocarcinoma
por: Kim, Eun Kyung, et al.
Publicado: (2017) -
Correlation of AR, EGFR, and HER2 Expression Levels in Prostate Cancer: Immunohistochemical Analysis and Chromogenic In Situ Hybridization
por: Baek, Kwang Hyun, et al.
Publicado: (2012) -
Peritoneal Fluid Cytology of Disseminated Large Cell Neuroendocrine Carcinoma Combined with Endometrioid Adenocarcinoma of the Endometrium
por: Lee, Yong-Moon, et al.
Publicado: (2019) -
Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer
por: Kim, Yun Gyoung, et al.
Publicado: (2017) -
Immunohistochemical expression of vegf and her-2 proteins in osteosarcoma biopsies
por: Becker, Ricardo Gehrke, et al.
Publicado: (2013)